Xu CF[au] - Search Results

Year	Number of Results
1982	1
1983	1
1985	2
1987	2
1988	1
1989	1
1990	4
1991	3
1992	3
1993	3
1994	5
1995	1
1996	4
1997	4
1998	2
1999	2
2000	2
2001	2
2002	5
2003	3
2004	8
2005	7
2006	3
2007	6
2008	13
2009	13
2010	15
2011	11
2012	9
2013	15
2014	18
2015	19
2016	17
2017	11
2018	13
2019	15
2020	10
2021	16
2022	7

1

Rational designs of in vivo CRISPR-Cas delivery systems.

Xu CF, Chen GJ, Luo YL, Zhang Y, Zhao G, Lu ZD, Czarna A, Gu Z, Wang J. Xu CF, et al. Adv Drug Deliv Rev. 2021 Jan;168:3-29. doi: 10.1016/j.addr.2019.11.005. Epub 2019 Nov 21. Adv Drug Deliv Rev. 2021. PMID: 31759123 Review.

2

Effect of dietary fiber on constipation: a meta analysis.

Yang J, Wang HP, Zhou L, Xu CF. Yang J, et al. Among authors: xu cf. World J Gastroenterol. 2012 Dec 28;18(48):7378-83. doi: 10.3748/wjg.v18.i48.7378. World J Gastroenterol. 2012. PMID: 23326148 Free PMC article.

3

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.

Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM. Li CX, et al. Among authors: xu cf. World J Gastroenterol. 2019 Sep 14;25(34):5120-5133. doi: 10.3748/wjg.v25.i34.5120. World J Gastroenterol. 2019. PMID: 31558861 Free PMC article.

4

Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy.

Jiang CT, Chen KG, Liu A, Huang H, Fan YN, Zhao DK, Ye QN, Zhang HB, Xu CF, Shen S, Xiong MH, Du JZ, Yang XZ, Wang J. Jiang CT, et al. Among authors: xu cf. Nat Commun. 2021 Mar 1;12(1):1359. doi: 10.1038/s41467-021-21497-6. Nat Commun. 2021. PMID: 33649336 Free PMC article.

5

Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer Therapy.

Ye QN, Wang Y, Shen S, Xu CF, Wang J. Ye QN, et al. Among authors: xu cf. Adv Healthc Mater. 2021 Jun;10(11):e2002139. doi: 10.1002/adhm.202002139. Epub 2021 Apr 18. Adv Healthc Mater. 2021. PMID: 33870637 Review.

6

Olfactomedin-4 in digestive diseases: A mini-review.

Wang XY, Chen SH, Zhang YN, Xu CF. Wang XY, et al. Among authors: xu cf. World J Gastroenterol. 2018 May 7;24(17):1881-1887. doi: 10.3748/wjg.v24.i17.1881. World J Gastroenterol. 2018. PMID: 29740203 Free PMC article. Review.

7

Development of "CLAN" Nanomedicine for Nucleic Acid Therapeutics.

Xu CF, Iqbal S, Shen S, Luo YL, Yang X, Wang J. Xu CF, et al. Small. 2019 Apr;15(16):e1900055. doi: 10.1002/smll.201900055. Epub 2019 Mar 18. Small. 2019. PMID: 30884095 Review.

8

Non-coding RNA in drug resistance of gastric cancer.

Luo YJ, Huang QM, Ren Y, Liu ZL, Xu CF, Wang H, Xiao JW. Luo YJ, et al. Among authors: xu cf. World J Gastrointest Oncol. 2019 Nov 15;11(11):957-970. doi: 10.4251/wjgo.v11.i11.957. World J Gastrointest Oncol. 2019. PMID: 31798777 Free PMC article. Review.

9

The genetics of drug efficacy: opportunities and challenges.

Nelson MR, Johnson T, Warren L, Hughes AR, Chissoe SL, Xu CF, Waterworth DM. Nelson MR, et al. Among authors: xu cf. Nat Rev Genet. 2016 Apr;17(4):197-206. doi: 10.1038/nrg.2016.12. Epub 2016 Mar 14. Nat Rev Genet. 2016. PMID: 26972588 Review.

10

DRD1 downregulation contributes to mechanical stretch-induced lung endothelial barrier dysfunction.

Wang Y, Liu YJ, Xu DF, Zhang H, Xu CF, Mao YF, Lv Z, Zhu XY, Jiang L. Wang Y, et al. Among authors: xu cf. Theranostics. 2021 Jan 1;11(6):2505-2521. doi: 10.7150/thno.46192. eCollection 2021. Theranostics. 2021. PMID: 33456556 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results